We are 2-Fluorobenzonitrile CAS:394-47-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Related News: The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.beta-Hydroxybutyric acid sodium salt According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.4-Methylphthalic Acid According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.2-Amino-3-nitropyridine CAS:4214-75-9 Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.
Product Name | |
---|---|
Ceric Nitrate Cas:13093-17-9 | View Details |
5,11-Dihydro-11,11-dimethylindeno[1,2-b]carbazole Cas:1260228-95-2 | View Details |
CAS:1558-24-3 Trichloro(dichloromethyl)silane | View Details |